Cargando…

Efficacy Evaluation of a Combined Hemorrhagic Septicemia–Mastitis Vaccine in Dairy Cows and Buffaloes

SIMPLE SUMMARY: Hemorrhagic septicemia (HS) and mastitis are important diseases of South Asian dairy animals. Seventy S. aureus/Str. agalactiae-free lactating buffaloes (n = 45) and cows (n = 25) and fifty S. aureus/Str. agalactiae-positive lactating (early stage of lactation) buffaloes (n = 25) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Qudratullah, Muhammad, Ghulam, Jamil, Tariq, Rashid, Imaad, Ullah, Qudrat, Saqib, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944738/
https://www.ncbi.nlm.nih.gov/pubmed/35327103
http://dx.doi.org/10.3390/ani12060706
Descripción
Sumario:SIMPLE SUMMARY: Hemorrhagic septicemia (HS) and mastitis are important diseases of South Asian dairy animals. Seventy S. aureus/Str. agalactiae-free lactating buffaloes (n = 45) and cows (n = 25) and fifty S. aureus/Str. agalactiae-positive lactating (early stage of lactation) buffaloes (n = 25) and cows (n = 25) were subjected to two doses of Montanide(®) adjuvant combined HS–mastitis vaccine with 21 days of interval. Vaccinated groups showed mean somatic cell counts and mastitis severity scores that were significantly lower (p < 0.05), whereas the milk yield was significantly higher (p < 0.05). In conclusion, this vaccine can be used as a potential preventive measure against HS and mastitis in dairy animals. ABSTRACT: Hemorrhagic septicemia (HS) and mastitis caused by Pasteurella (P.) multocida, Staphylococcus (S.) aureus and Streptococcus (Str.) agalactiae are important ailments of the dairy industry especially in South Asia. The present study evaluates the efficacy of a locally prepared hemorrhagic septicemia (HS) and mastitis combined vaccine. To this end, a total of 70 HS, S. aureus and Str. agalactiae-free lactating (early stage of lactation) buffaloes (n = 45) and cows (n = 25), and 50 lactating (early stage of lactation) cows (n = 25) and buffaloes (n = 25) positive for S. aureus/Str. agalactiae were subjected to two doses of HS–mastitis combined vaccine with an interval of 21 days. Antibody response was monitored by ELISA up to six months (180 days). Antibody titers against HS and mastitis were significantly (p ˂ 0.05) higher in vaccinated groups as compared to the non-vaccinated groups. Cumulative mean somatic cell counts and mastitis severity scores in vaccinated groups were significantly lower (p < 0.05), and milk yield was significantly higher (p < 0.05) than those in the respective non-vaccinated controls. In conclusion, Montanide(®)-adjuvanted HS–mastitis combined vaccine showed significant immunogenic effects in dairy cows and buffaloes. However, challenge studies remain overdue.